Emerging trends: Covalent inhibitors
With over 50 approved drugs currently on the market, covalent inhibitors seem to be a hot topic! Find out what all the fuss is about and we’re doing to stay on top of things.
We are in the January issue of HiPEAC magazine, presenting our PyDock technology for drug design and discovery.
Check it out !
Javier Iglesias appointed as new Division Leader of the Enzyme Engineering division
Dr. Iglesias, who recently joined NBD as Project Manager for the Nucleic Acids Division, has been internally promoted to substitute the...
Check the new article of our worker Joan Coines, in which he engineered a glycosyltransferase able to efficiently catalyze N-, O-, or S-glycosylation. More #enzymeengineering expertise on board!